Shares of Neogen (NASDAQ:NEOG) decreased 0.8% in pre-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share decreased 51.61% over the past year to $0.15, which missed the estimate of $0.16.
Neogen (NASDAQ:NEOG) reported quarterly earnings of $0.15 per share which missed the analyst consensus estimate of $0.16 by 6.25 percent. This is a 51.61 percent decrease over earnings of $0.31 per share from the same
Companies Reporting Before The Bell
• Signature Bank (NASDAQ:SBNY) is likely to report quarterly earnings at $3.14 per share on revenue of $466.52 million.
NEOGEN Corporation (NASDAQ:NEOG) announced today that they have extended their strategic partnership with genomics software company Gencove, Inc. to continue providing robust and innovative animal genomic
Soleris® Direct Yeast and Mold test has received the Performance Tested MethodsSM Certification from the AOAC Research Institute's Emergency Response Validation Process for the enumeration of yeasts and